Identification of Novel Inhibitors against Coactivator Associated Arginine Methyltransferase 1 Based on Virtual Screening and Biological Assays
- PMID: 27872854
- PMCID: PMC5107250
- DOI: 10.1155/2016/7086390
Identification of Novel Inhibitors against Coactivator Associated Arginine Methyltransferase 1 Based on Virtual Screening and Biological Assays
Abstract
Overexpression of coactivator associated arginine methyltransferase 1 (CARM1), a protein arginine N-methyltransferase (PRMT) family enzyme, is associated with various diseases including cancers. Consequently, the development of small-molecule inhibitors targeting PRMTs has significant value for both research and therapeutic purposes. In this study, together with structure-based virtual screening with biochemical assays, two compounds DC_C11 and DC_C66 were identified as novel inhibitors of CARM1. Cellular studies revealed that the two inhibitors are cell membrane permeable and effectively blocked proliferation of cancer cells including HELA, K562, and MCF7. We further predicted the binding mode of these inhibitors through molecular docking analysis, which indicated that the inhibitors competitively occupied the binding site of the substrate and destroyed the protein-protein interactions between CARM1 and its substrates. Overall, this study has shed light on the development of small-molecule CARM1 inhibitors with novel scaffolds.
Figures



Similar articles
-
Virtual screening and biological evaluation of novel small molecular inhibitors against protein arginine methyltransferase 1 (PRMT1).Org Biomol Chem. 2014 Dec 21;12(47):9665-73. doi: 10.1039/c4ob01591f. Epub 2014 Oct 28. Org Biomol Chem. 2014. PMID: 25348815
-
Virtual Screening with a Structure-Based Pharmacophore Model to Identify Small-Molecule Inhibitors of CARM1.J Chem Inf Model. 2019 Jan 28;59(1):522-534. doi: 10.1021/acs.jcim.8b00610. Epub 2019 Jan 16. J Chem Inf Model. 2019. PMID: 30607947
-
Identification of Selective, Cell Active Inhibitors of Protein Arginine Methyltransferase 5 through Structure-Based Virtual Screening and Biological Assays.J Chem Inf Model. 2018 May 29;58(5):1066-1073. doi: 10.1021/acs.jcim.8b00050. Epub 2018 Apr 26. J Chem Inf Model. 2018. PMID: 29672052
-
A patent review of arginine methyltransferase inhibitors (2010-2018).Expert Opin Ther Pat. 2019 Feb;29(2):97-114. doi: 10.1080/13543776.2019.1567711. Expert Opin Ther Pat. 2019. PMID: 30640571 Review.
-
Small Molecule Inhibitors of Protein Arginine Methyltransferases.Expert Opin Investig Drugs. 2016;25(3):335-58. doi: 10.1517/13543784.2016.1144747. Epub 2016 Feb 16. Expert Opin Investig Drugs. 2016. PMID: 26789238 Free PMC article. Review.
Cited by
-
Unconventional protein post-translational modifications: the helmsmen in breast cancer.Cell Biosci. 2022 Feb 25;12(1):22. doi: 10.1186/s13578-022-00756-z. Cell Biosci. 2022. PMID: 35216622 Free PMC article. Review.
-
METTL3 Inhibitors for Epitranscriptomic Modulation of Cellular Processes.ChemMedChem. 2021 Oct 6;16(19):3035-3043. doi: 10.1002/cmdc.202100291. Epub 2021 Jul 29. ChemMedChem. 2021. PMID: 34237194 Free PMC article.
-
Discovery and Preliminary Characterization of Translational Modulators that Impair the Binding of eIF6 to 60S Ribosomal Subunits.Cells. 2020 Jan 10;9(1):172. doi: 10.3390/cells9010172. Cells. 2020. PMID: 31936702 Free PMC article.
-
Inhibition of eIF6 Activity Reduces Hepatocellular Carcinoma Growth: An In Vivo and In Vitro Study.Int J Mol Sci. 2022 Jul 13;23(14):7720. doi: 10.3390/ijms23147720. Int J Mol Sci. 2022. PMID: 35887068 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources